In shocking reversal, Biogen to submit Alzheimer's drug for approval

In shocking reversal, Biogen to submit Alzheimer's drug for approval

In shocking reversal, Biogen to submit experimental Alzheimer’s drug for approval

By MATTHEW HERPER

NATIONAL INSTITUTE ON AGING, NIH

Biogen said it would resurrect an Alzheimer’s drug that the company previously said had failed and will ask the Food and Drug Administration to approve it.

READ MORE